Dr Reddys Laboratories annual return on equity
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories Return on Equity (ROE) Growth & History (RDY)
Dr Reddys Laboratories's return on equity was 18.46% for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | 18.46% | −3.17 pp |
| 2024 | 2024-03-31 | 21.63% | +1.03 pp |
| 2023 | 2023-03-31 | 20.60% | +7.84 pp |
| 2022 | 2022-03-31 | 12.75% | +2.08 pp |
| 2021 | 2021-03-31 | 10.67% | −2.01 pp |
| 2020 | 2020-03-31 | 12.69% | −1.02 pp |
| 2019 | 2019-03-31 | 13.71% | — |
Dr Reddys Laboratories return on equity trends
Over the last five fiscal years, Dr Reddys Laboratories's return on equity increased from 12.69% to 18.46%, a change of +5.78 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗